The marketing of a new drug requires several years of effort and a variety of tests to demonstrate its safety and effectiveness.
Clinical studies in humans are one of the final stages of this process. Clinical studies conducted by inVentiv generally aim to assess the body’s extent of absorption and elimination of study drugs. To do this, we have been enrolling several hundred volunteers annually for 20 years. Their role is crucial, since no drug can be marketed without their contribution. Study participants receive compensation payments for any inconveniences associated with their participation.
There are several reasons for our volunteers to participate in our clinical studies.
Sign up for our newsletter and be among the first to receive information on any new clinical study offers. By entering your email address below, you agree to receive information emails from inVentiv. You may also provide your mobile phone number to be informed of future studies via text messaging.
You may unsubscribe at any time.